Capital expenditure decreased 62.7%
Capital expenditure changed -62.7% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -62.7% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Selling, general & administrative changed +33.6% from the comparable as-filed period.
Gross margin changed -158 basis points from the comparable as-filed period.
Operating income changed -16.4% from the comparable as-filed period.
Net income changed -14.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +192 basis points from the comparable as-filed period.
Gross profit changed +20.9% from the comparable as-filed period.
Stock-based compensation changed +21.2% from the comparable as-filed period.
SBC / revenue changed -5 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.